loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..
'indian ip and liabilities law barrier to pharma r&d investment'
. 18 hours ago.
on saturday, may 5, with her husband beside her, helen's condition turned grave...